BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS)
$0.0484 0.0061 (14.4208%)
Analysed BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) News Sources
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
10-03-2026
yahoo.com
BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer
29-01-2026
yahoo.com
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
20-01-2026
yahoo.com
BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer
08-01-2026
yahoo.com
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
17-12-2025
yahoo.com
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
19-11-2025
yahoo.com
BioVaxys Announces Extension of Life Offering Closing Date
11-11-2025
yahoo.com
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
30-10-2025
yahoo.com
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
28-10-2025
yahoo.com
BioVaxys Technology Announces Conversion of Debentures
22-10-2025
yahoo.com
What is the current price of BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS)?
The current price of BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) is $0.0484.
BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) since the previous trading day is $0.0061.
BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) since the previous trading day is 14.4208%.
What is the most recent average sentiment score for BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS)?
The most recent average sentiment score for BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS)?
The most recent sentiment for BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS) is .
SEC-8K** Filing Available For BIOVAXYS TECHNOLOGY CORP (BVAXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.